CSL Drops on $760m: Puts Pressure on Super Retail Stock
CSL, one of Australia’s market leaders in biopharmaceuticals, saw a sharp market reaction after news of a $760 million financial hit. The move rattled the ASX, and the shockwaves reached the retail sector, putting pressure on Super Retail Group shares. Traders and fund managers cited risk-off flows, and investors began to reassess sector exposure across…